Clinical Characteristics of Covid-19 in New York City

Goyal, Parag, Choi, Justin J., Pinheiro, Laura C., Schenck, Edward J., Chen, Ruijun, Jabri, Assem, Satlin, Michael J., Campion, Thomas R. +13 more·2020·New England Journal of Medicine
DOI 10.1056/nejmc2010419

Cited by (1,001)

Items 701–800 of 1,001

  1. Statewide Real-Time Tracking of Beds and Ventilators During Coronavirus Disease 2019 and Beyond
    Matthias Johannes Merkel, Renee Edwards, Joe Ness, Carl O. Eriksson, Susan Yoder, Stephanie Gilliam, Katie Ellero, Coral Barreto-Costa, Peter F. Graven, Jeffrey R. Terry et al. · 2020 · Critical Care Explorations
  2. Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees
    Faryal I. Farooqi, Richard C. Morgan, Naveen Dhawan, John Dinh, George D. Yatzkan, George Michel · 2020 · American Journal of Case Reports
  3. COVID-19 Associated Coagulopathy and Thrombotic Complications
    Zoubida Mezalek Tazi, Hajar Khibri, Wafaa Ammouri, Majdouline Bouaouad, Soukaina Haidour, H. Harmouche, M. Maamar, Mohamed Adnaoui · 2020 · Clinical and Applied Thrombosis/Hemostasis
  4. The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study
    Qin Sun, Jianfeng Xie, Ruiqiang Zheng, Xuyan Li, Hui Chen, Zhaohui Tong, Bin Du, Haibo Qiu, Yi Yang · 2020 · International Immunopharmacology
  5. MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection
    Lanlan Zhou, Kelsey E. Huntington, Shengliang Zhang, Lindsey Carlsen, Eui Young So, Cassandra Parker, İlyas Şahin, Howard P. Safran, Suchitra Kamle, Chang-Min Lee et al. · 2020 · Oncotarget
  6. Development and validation of prediction models for mechanical ventilation, renal replacement therapy, and readmission in COVID-19 patients
    Victor Rodriguez, Shreyas Bhave, Ruijun Chen, Chao Pang, George M. Hripcsak, Soumitra Sengupta, Noémie Elhadad, Robert Green, Jason S. Adelman, Katherine R Schlosser et al. · 2021 · Journal of the American Medical Informatics Association
  7. Clinical features of 47 patients infected with COVID-19 admitted to a Regional Reference Center
    Felipe Olivares, Daniel López Muñoz, Alberto Fíca, Ignacio Delama, Ignacia Alvarez, Maritza Navarrete C, Eileen Blackburn, Pamela Garrido, Ricardo Wenger, Juan Grandjean · 2020 · Revista médica de Chile
  8. Epidemiology, Clinical Features, and Outcomes of Hospitalized Adults with COVID-19: Early Experience from an Academic Medical Center in Mississippi
    Jose A Lucar, Mary Joyce B. Wingler, David A. Cretella, Lori M. Ward, Courtney E. Sims-Gomillia, Nicholas Chamberlain, Luis A. Shimose, James Benjamin Brock, Jessie Harvey, Andrew Wilhelm et al. · 2021 · Southern Medical Journal
  9. Role of Cardiac Biomarkers in COVID-19: What Recent Investigations Tell Us?
    Shahzad Maqsood Khan, Sahibzada Tasleem Rasool, Syed Imran Ahmed · 2021 · Current Problems in Cardiology
  10. Increased incidence of post-operative respiratory failure in patients with pre-operative SARS-CoV-2 infection
    Michael E. Kiyatkin, Samantha P. Levine, Atsumi Kimura, Ryan W. Linzer, Jacqueline R. Labins, Joseph I. Kim, Aryeh Gurvich, Michelle N. Gong · 2021 · Journal of Clinical Anesthesia
  11. Dysphagia, Dysphonia, and Dysarthria Outcomes Among Adults Hospitalized With COVID ‐19 Across Ireland
    Julie Regan, Margaret Walshe, Sarah Lavan, Eanna Horan, Patricia Gillivan Murphy, Anne Healy, Caoimhe Langan, Karen Malherbe, Breda Flynn Murphy, Maria Cremin et al. · 2021 · The Laryngoscope
  12. Endothelial Transcytosis in Acute Lung Injury: Emerging Mechanisms and Therapeutic Approaches
    Joshua H. Jones, Richard D. Minshall · 2022 · Frontiers in Physiology
  13. Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19)
    Banlambhabok Khongthaw, Kanika Dulta, P.K. Chauhan, Vinod Kumar, Joshua O. Ighalo · 2022 · Inflammopharmacology
  14. COVID-19: Pharmacology and kinetics of viral clearance
    Nicola Farina, Giuseppe Alvise Ramirez, Rebecca DE LORENZO, Luigi di Filippo, Caterina Conte, Fabio Ciceri, Angelo Andrea Manfredi, Patrizia Querini Rovere · 2020 · Pharmacological Research
  15. Racial disparities in Coronavirus Disease 2019 (COVID-19) outcomes
    Yeabsra Aleligne, Duke Appiah, Imo Ebong · 2021 · Current Opinion in Cardiology
  16. Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System
    Jairo Lumpuy‐Castillo, Ana Lorenzo-Almorós, Ana María Pello Lázaro, Carlos F. Sánchez‐Ferrer, Jesús Egido, José Tuñón, Concepción Peiró, Óscar Lorenzo · 2020 · International Journal of Molecular Sciences
  17. Effects of Covid-19 on male reproductive system
    Matheus Ferreira Gröner, Renata Cristina de Carvalho, Jacqueline Camillo, Paulo Roberto Abrão Ferreira, Renato Fraietta · 2020 · International braz j urol
  18. Early predictors for mechanical ventilation in COVID-19 patients
    Wen Li, Fengyu Lin, Minhui Dai, Lingli Chen, Duoduo Han, Yanhui Cui, Pinhua Pan · 2020 · Therapeutic Advances in Respiratory Disease
  19. Thyrotoxic Crisis and COVID-19 Infection: An Extraordinary Case and Literature Review
    Silvia Pastor, Ángeles Molina, Elena de Celis · 2020 · Cureus
  20. Complement activation and coagulopathy - an ominous duo in COVID19
    Sojit Tomo, Kiran Pvsn Kumar, Dipayan Roy, Shrimanjunath Sankanagoudar, Purvi Purohit, Dharamveer Yadav, Mithu Banerjee, Praveen Sharma, Sanjeev Misra · 2021 · Expert Review of Hematology
  21. Clinical characteristics and outcomes of children with COVID-19 in Saudi Arabia
    Abeer A. Alnajjar, Ahmed Mohamed Dohain, Gaser Abdelmohsen, Turki S Alahmadi, Zaher F. Zaher, Abobakr Abosree Abdelgalil · 2021 · Saudi Medical Journal
  22. Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation
    Gregorio Zaccone, Daniela Tomasoni, Leonardo Italia, Carlo Lombardi, Marco Metra · 2021 · Current Heart Failure Reports
  23. Variation in COVID-19 characteristics, treatment and outcomes in Michigan: an observational study in 32 hospitals
    Vineet Chopra, Scott A. Flanders, Valerie M. Vaughn, Lindsay A Petty, Tejal N. Gandhi, Jakob Israel McSparron, Anurag N. Malani, Megan O’Malley, Tae Il Kim, Elizabeth S. McLaughlin et al. · 2021 · BMJ Open
  24. The role of exercise in rehabilitation of discharged COVID-19 patients
    Wenyan Bo, Yue Xi, Zhenjun Tian · 2021 · Sports Medicine and Health Science
  25. Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-19 infection
    Takafumi Saito, Tetsuo Yamaguchi, Shunsuke Kuroda, Takeshi Kitai, Taishi Yonetsu, Shun Kohsaka, Sho Torii, Koichi Node, Shingo Matsumoto, Yuya Matsue et al. · 2021 · Journal of Cardiology
  26. Mortality Predictors in Severe COVID-19 Patients from an East European Tertiary Center: A Never-Ending Challenge for a No Happy Ending Pandemic
    Amalia Stefana Țimpău, Radu-Ştefan Miftode, Antoniu Octavian Petriş, Irina Iuliana Costache, Ionela-Larisa Miftode, Florin Manuel Roşu, Dana-Teodora Anton-Păduraru, Daniela A. Leca, Egidia Gabriela Miftode · 2021 · Journal of Clinical Medicine
  27. Azithromycin Misuse During the COVID-19 Pandemic: A Cross-Sectional Study from Jordan
    Suzanne M. A. Abdelmalek, Abdelrahman Mousa · 2022 · Infection and Drug Resistance
  28. Factors Associated With COVID-19 Death in the United States: Cohort Study
    Uan‐I Chen, Hua Xu, Trudy Millard Krause, Raymond S. Greenberg, Xiao Dong, Xiaoqian Jiang · 2022 · JMIR Public Health and Surveillance
  29. Overweight and Obesity in Saudi Arabia: Consequences and Solutions
    Mohammed Alluhidan, Reem F. Alsukait, Taghred Alghaith, Meera Shekar, Nahar Alazemi, Christopher H. Herbst · 2022 · World Bank, Washington, DC eBooks
  30. Initial Inoculum and the Severity of COVID-19: A Mathematical Modeling Study of the Dose-Response of SARS-CoV-2 Infections
    Baylor G. Fain, Hana M. Dobrovolny · 2020 · Epidemiologia
  31. Comorbidity and Sociodemographic determinants in COVID-19 Mortality in an US Urban Healthcare System
    An‐Li Wang, Xiaobo Zhong, Yasmin L. Hurd · 2020 · medRxiv
  32. ADLM Guidance Document on Laboratory Diagnosis of Respiratory Viruses
    Gregory J. Berry, Tulip A. Jhaveri, Paige M. K. Larkin, Heba H. Mostafa, N. Esther Babady · 2024 · The Journal of Applied Laboratory Medicine
  33. Learning health system strategies in the AI era
    Peter A.D. Steel, Gabriel Wardi, Robert A. Harrington, Chris Longhurst · 2025 · npj Health Systems
  34. HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic
    Niraj Varma, Nassir F. Marrouche, Luis Aguinaga, Christine M. Albert, Elena Arbelo, Jong‐Il Choi, Mina K. Chung, Giulio Conte, Lilas Dagher, Laurence Mark Epstein et al. · 2020 · Heart Rhythm
  35. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease
    Michael J. Satlin, Parag Goyal, Reed Magleby, Grace A. Maldarelli, Khanh Pham, Maiko Kondo, Edward James Schenck, Hanna Rennert, Lars F. Westblade, Justin J. Choi et al. · 2020 · PLoS ONE
  36. Principles and treatment strategies for the use of Chinese herbal medicine in patients at different stages of coronavirus infection.
    Sheng‐Teng Huang, Hsiang-Chun Lai, Yu‐Chun Lin, Wei-Te Huang, Hao-Hsiu Hung, Shi‐Chen Ou, Hung‐Jen Lin, Mien‐Chie Hung · 2020 · PubMed Central
  37. Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review
    Szilárd Váncsa, Péter Hegyi, Noémi Zádori, Lajos Szakó, Nóra Vörhendi, Klementina Ocskay, Mária Földi, Fanni Dembrovszky, Zsuzsa Réka Dömötör, Kristof-Ferenc Janosi et al. · 2020 · Frontiers in Medicine
  38. Radiologic aspects of COVID-19 pneumonia: Outcomes and thoracic complications
    María Luz Parra Gordo, G. Buitrago Weiland, M. Grau García, Gorka Arenaza Choperena · 2021 · Radiología (English Edition)
  39. Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID‐19)
    Andrew D. Santeusanio, Madhav C. Menon, Caroline Liu, Arjun Bhansali, Niralee Patel, Fahima Mahir, Meenakshi M. Rana, Fasika M. Tedla, Ahmad Mahamid, Yaniv Fenig et al. · 2021 · Clinical Transplantation
  40. Contribution of pulmonary diseases to COVID-19 mortality in a diverse urban community of New York
    Girardin Jean‐Louis, Azizi A Seixas, Jaime Ramos‐Cejudo, Ricardo S. Osorio, George Avirappattu, Marvin Ellsworth Reid, Sairam Parthasarathy · 2021 · Chronic Respiratory Disease
  41. Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean
    Mara García-Posada, Sandra Aruachan-Vesga, Danis Mestra Rojas, Katherine Humánez, Hector Alejandro Serrano Coll, Heriberto José Cabrales Dajil, Álvaro Faccini, Salim Mattar V · 2021 · Journal of Infection and Public Health
  42. New‐onset atrial fibrillation in critically ill patients with coronavirus disease 2019 (COVID‐19)
    Bişar Ergün, Begüm Ergan, Melih Kaan Sözmen, Murat Küçük, Mehmet Nuri Yakar, Bilgin Cömert, Ali Necati Gökmen, Erdem Yaka · 2021 · Journal of Arrhythmia
  43. Clinical course and outcome of patients with COVID-19 in Mumbai City: an observational study
    Rosemarie de Souza, Sharayu Mhatre, Burhanuddin Nuruddin Qayyumi, Garvit Chitkara, Tushar Madke, Mohan Joshi, Ramesh N. Bharmal, Dileep Asgaonkar, Prem Lakhani, Sudeep Gupta et al. · 2021 · BMJ Open
  44. Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease
    Taru S. Dutt, Stephanie M LaVergne, Tracy L Webb, Bridget A Baxter, Sophia Stromberg, Kim McFann, Kailey Berry, Madison Tipton, Omar Alnachoukati, Linda Zier et al. · 2022 · The Journal of Immunology
  45. COVID-19: mortality rates of patients on hemodialysis and peritoneal dialysis
    Demet Yavuz, Düriye Sıla Karagöz Özen, Mehmet Derya Demirağ · 2022 · International Urology and Nephrology
  46. The role of blood urea nitrogen to serum albumin ratio in the prediction of severity and 30‐day mortality in patients with COVID‐19
    Toktam Alirezaei, Saeede Hooshmand, Rana Irilouzadian, Behzad Hajimoradi, Sadra Montazeri, Arash Shayegh · 2022 · Health Science Reports
  47. Incidence, Risk Factors, and Prognosis of Bloodstream Infections in COVID-19 Patients in Intensive Care: A Single-Center Observational Study
    Ahmet Furkan Kurt, Bilgül Mete, Seval Ürkmez, Oktay Demirkıran, Güleren Yartaş Dumanlı, Süha Bozbay, Olcay Dilken, Rıdvan Karaali, İ̇lker İnanç Balkan, Neşe Saltoğlu et al. · 2022 · Journal of Intensive Care Medicine
  48. Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients
    Mehmet Emin Arayıcı, Nazlican Kipcak, Ufuktan Kayacik, Cansu Kelbat, Deniz Keskin, Muhammed Emin Kilicarslan, Ahmet Veli Kilinc, Sumeyye Kirgoz, Anil Kirilmaz, Melih Alihan Kizilkaya et al. · 2022 · Journal of Cancer Research and Clinical Oncology
  49. Diabetes and COVID-19 risk: an miRNA perspective
    Paras Kumar Mishra, Ritesh Tandon, Siddappa N. Byrareddy · 2020 · American Journal of Physiology-Heart and Circulatory Physiology
  50. Blood component utilization in COVID‐19 patients in New York City: Transfusions do not follow the curve
    Robert Andrew Desimone, Victoria A. Costa, Kathleen Kane, Jorge L. Sepulveda, Grant B. Ellsworth, Roy M. Gulick, Jason E Zucker, Magdalena E Sobieszcyk, Joseph E. Schwartz, Melissa M. Cushing · 2020 · Transfusion
  51. Impact of Obesity and Its Associated Comorbid Conditions on COVID-19 Presentation
    Osama Mahmoud Mehanna, Ahmad El Askary, Ebtesam Ali, Basem Hassan Elesawy, Tamer FathAlla, Amal Fathi Gharib · 2021 · Diabetes Metabolic Syndrome and Obesity
  52. Association between procalcitonin levels and duration of mechanical ventilation in COVID-19 patients
    Martín Krause, David J. Douin, Timothy T. Tran, Ana Fernandez-Bustamante, Muhammad Aftab, Karsten Bartels · 2020 · PLoS ONE
  53. Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies—need for data validation of the completed trials and to improve ongoing and future randomised trial designs
    Venkata R. Emani, Sanjeev Goswami, Dheeraj Nandanoor, Shaila R. Emani, Nidhi K. Reddy, Raghunath Reddy · 2020 · International Journal of Antimicrobial Agents
  54. COVID-19 in Patients with CKD in New York City
    Oleh M. Akchurin, Kelly Meza, Sharmi Biswas, Michaela Greenbaum, Alexandra Pilar Licona-Freudensten, Parag Goyal, Justin J. Choi, Mary E. Choi · 2020 · Kidney360
  55. Surge effects and survival to hospital discharge in critical care patients with COVID-19 during the early pandemic: a cohort study
    Christopher R. Dale, Rachael Whitley Starcher, Shu‐Ching Chang, Ari A. Robicsek, Guilford Parsons, Jason D. Goldman, Andre Vovan, David L. Hotchkin, Tyler J Gluckman · 2021 · Critical Care
  56. Pre-Existing Cytokine and NLRP3 Inflammasome Activation and Increased Vascular Permeability in Diabetes: A Possible Fatal Link With Worst COVID-19 Infection Outcomes?
    Vaia Lambadiari, Foteini Kousathana, Athanasios E. Raptis, Konstantinos Katogiannis, Alexander D. Kokkinos, Ignatios Ikonomidis · 2020 · Frontiers in Immunology
  57. The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients
    Seán Boyd, Ignacio Martín‐Loeches · 2021 · Irish Journal of Medical Science (1971 -)
  58. Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: Challenges and opportunities
    Christine J. Kubin, Angela S. Loo, Jennifer Cheng, Brian C. Nelson, Monica Mehta, Shawn Mazur, Wonhee So, David P. Calfee, Harjot Kaur Singh, William G. Greendyke et al. · 2021 · American Journal of Health-System Pharmacy
  59. Prevalence and mortality of lung comorbidities among patients with COVID-19
    Mohammed Alkhathami, Shailesh M Advani, Adil A. Abalkhail, Fahad M Alkhathami, Mohammed K. Alshehri, Ebtisam Albeashy, Jihad A Alsalamah · 2021 · Lung India
  60. COVID-19 IgG-related autoimmune inflammatory necrotizing myositis
    Maedeh Veyseh, Sai Koyoda, Bibi Ayesha · 2021 · BMJ Case Reports
  61. Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic
    Robert G. Micheletti · 2021 · Cutis
  62. COVID-19 in trauma: a propensity-matched analysis of COVID and non-COVID trauma patients
    Eric O. Yeates, Areg Grigorian, Morgan A. Schellenberg, Natthida Owattanapanich, Galinos Barmparas, Daniel R. Margulies, Catherine J. Juillard, Kent David Garber, Henry Cryer, Areti Tillou et al. · 2021 · European Journal of Trauma and Emergency Surgery
  63. The Impact of Obesity on Critical Illnesses
    Itay Ayalon, Lauren Bodilly, Jennifer Kaplan · 2021 · Shock
  64. Predictive Value of Neutrophil/Lymphocyte Ratio (NLR) on Cardiovascular Events in Patients with COVID-19
    Lili Zhan, Yang Liu, Yanxiang Cheng, Weichun Guo, Jing Yang · 2021 · International Journal of General Medicine
  65. Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals
    Sabrina Racine‐Brzostek, Jim K. Yee, Ashley C. Sukhu, Yuqing Qiu, Sophie Rand, Paul Dylan Barone, Ying Hao, He S. Yang, Qing H. Meng, Fred S. Apple et al. · 2021 · JCI Insight
  66. Distinct Roles of Type I and Type III Interferons during a Native Murine β Coronavirus Lung Infection
    Lokesh Sharma, Xiaohua Peng, Hua Qing, Brandon K. Hilliard, Jooyoung Kim, Anush Swaminathan, Justin Tian, Kavita Israni-Winger, Cuiling Zhang, Victoria Habet et al. · 2021 · Journal of Virology
  67. Recent Advances in the Impact of Infection and Inflammation on Stroke Risk and Outcomes
    Stephanie E. Oh, Neal S. Parikh · 2022 · Current Neurology and Neuroscience Reports
  68. Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry
    Norbert Stefan, Katrin Sippel, Martin Heni, Andreas Fritsche, Robert J. Wagner, Carolin E. M. Jakob, Hubert T. Preissl, Alexander von Werder, Yascha Khodamoradi, Stefan Borgmann et al. · 2022 · Frontiers in Medicine
  69. SARS-CoV-2 can infect human embryos
    Mauricio Montaño, Andrea R. Victor, Darren Karl Griffin, Tommy Duong, Nathalie Bolduc, Andrew A. Farmer, Vidur Garg, Anna‐Katerina Hadjantonakis, Alison Coates, Frank L. Barnes et al. · 2022 · Scientific Reports
  70. A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease
    Keynaz Keykavousi, Fahimeh Nourbakhsh, Nooshin Abdollahpour, Farzaneh Fazeli, Alireza Sedaghat, Vahid Soheili, Amirhossein Sahebkar · 2022 · International Journal of Analytical Chemistry
  71. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study
    Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, Prabhu S. Arunachalam, Diego AM Mori, Karen Blake Jacobson, Hector Fabio Bonilla, Julie Parsonnet, Jason Randolph Andrews, Marisa K. Holubar et al. · 2022 · eLife
  72. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice
    Côme Thieulent, Wellesley Dittmar, Udeni B. R. Balasuriya, Nicholas A. Crossland, Xue Wen, Jüergen A. Richt, Mariano Carossino · 2023 · mSphere
  73. Prevalence of Bloodstream Infections and their Etiology in COVID-19 Patients Admitted in a Tertiary Care Hospital in Jaipur
    Hemant Malhotra, Daisy Bacchani, Ved Prakash Mamoria · 2021 · Indian Journal of Critical Care Medicine
  74. Risk Factors of Clonally Related, Multi, and Extensively Drug‐Resistant Acinetobacter baumannii in Severely Ill COVID‐19 Patients
    Meqdad Saleh Ahmed, Zirak Faqe Ahmed Abdulrahman, Zanan Mohammed Ameen Taha · 2023 · Canadian Journal of Infectious Diseases and Medical Microbiology
  75. Single-cell multiomics reveal divergent effects of DNMT3A- and TET2- mutant clonal hematopoiesis in inflammatory response
    Wazim Mohammed Ismail, Jenna A. Fernandez, Moritz Binder, Terra L. Lasho, Minsuk Kim, Susan Michelle Geyer, Amelia Mazzone, Christy M. Finke, Abhishek Avinash Mangaonkar, Jeong‐Heon Lee et al. · 2024 · Blood Advances
  76. Characterization of Critically Ill COVID-19 Patients at a Brooklyn Safety-Net Hospital
    Stephen Capone, Shogik Abramyan, B. Ross, Joshua R. Rosenberg, John Zeibeq, Viswanath P. Vasudevan, Reza Samad, Louis N. Gerolemou, Evgeny Pinelis, James Gasperino et al. · 2020 · Cureus
  77. Thirty-Day Post-Discharge Outcomes Following COVID-19 Infection
    Justin R. Kingery, Paul BF Martin, Ben R. Baer, Laura C. Pinheiro, Mangala Rajan, Adrienne Clermont, Sabrina Pan, Khoi Nguyen, Khalid Fahoum, Graham T. Wehmeyer et al. · 2021 · Journal of General Internal Medicine
  78. Characteristics, treatment, and outcomes of Myasthenia Gravis in COVID-19 patients: A systematic review
    Alzhraa Salah Abbas, Nicole J. Hardy, Sherief A. Ghozy, Mahmoud Dibas, Geeta S. Paranjape, Kirk W. Evanson, Natalie L. Reierson, Kathryn Cowie, Shelby Kamrowski, Scarlett Schmidt et al. · 2022 · Clinical Neurology and Neurosurgery
  79. A clinical profile of infective endocarditis in patients with recent COVID-19: A systematic review
    Juan Andres Quintero-Martinez, Joya-Rita Hindy, Maryam Mahmood, Dana Gerberi, Daniel Christopher DeSimone, Larry M. Baddour · 2022 · The American Journal of the Medical Sciences
  80. The Cytokine Storm in COVID-19: The Strongest Link to Morbidity and Mortality in the Current Epidemic
    Maamoun Basheer, Elias Saad, Nimer Assy · 2022 · COVID
  81. Proteomic characterization of acute kidney injury in patients hospitalized with SARS-CoV2 infection
    Ishan Paranjpe, Pushkala Jayaraman, Chen‐Yang Su, Sirui Zhou, Steven Chen, Ryan C. Thompson, Diane Marie Del Valle, Ephraim Kenigsberg, Shan Zhao, Suraj K. Jaladanki et al. · 2023 · Communications Medicine
  82. Immunomodulatory Effects of Vitamin D and Zinc on Viral Infection
    Muhammad Rizwan, Ke Cheng, Yang Gang, Yuntao Hou, Chunfang Wang · 2024 · Biological Trace Element Research
  83. High-value Laboratory Testing for Hospitalized COVID-19 Patients: A Review
    Daniela Čiháková, Michael Blake Streiff, Steven P. Menez, Teresa K. Chen, Nisha Aggarwal Gilotra, Erin D. Michos, Kieren A. Marr, Andrew H. Karaba, Matthew L. Robinson, Paul W. Blair et al. · 2021 · Future Virology
  84. Investigation of subsequent and co-infections associated with SARS-CoV-2 (COVID-19) in hospitalized patients
    Matthew P. Crotty, Ronda L. Akins, An Nguyen, Rania Slika, Kristen Rahmanzadeh, Marie H. Wilson, Edward A. Dominguez · 2020 · medRxiv
  85. Diabetes and deaths of COVID-19 patients: Systematic review of meta-analyses
    Aakriti Garg, Mahesh Kumar Posa, Anoop Kumar · 2023 · Health Sciences Review
  86. Hyperreninemia and low total body water may contribute to acute kidney injury in COVID-19 patients in intensive care
    Michael Hultström, Magnus von Seth, Robert Frithiof · 2020 · Journal of Hypertension
  87. COVID-19 in Patients With Seizures and Epilepsy: Interpretation of Relevant Knowledge of Presenting Signs and Symptoms
    Robert Edward Hogan, Zachary M. Grinspan, Erika Takle Axeen, B. Oyinkan Marquis, Brian Keith Day · 2020 · Epiliepsy currents/Epilepsy currents
  88. Extrapulmonary Features of COVID-19: A Concise Review
    RadhikaShriprakash Ruhatiya, Sachin A Adukia, Ramya Ballekatte Manjunath, Gagan Jain · 2020 · Indian Journal of Critical Care Medicine
  89. Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020
    Thomas Scheier, Adrian Schibli, Geri Eich, Christian Rüegg, Frank Kube, Adrian Schmid, Urs W. Karrer, Aline Wolfensberger, Hugo Sax, Peter Werner Schreiber · 2021 · Emerging infectious diseases
  90. Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19
    Devjit Roy, Justin Song, Nirvana Awad, Paul Zamudio · 2021 · BMJ Case Reports
  91. Trends Over Time in the Risk of Adverse Outcomes Among Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    George N. Ioannou, Ann M. O’Hare, Kristin Berry, Vincent S. Fan, Kristina A. Crothers, McKenna C. Eastment, Emily R. Locke, Pamela K. Green, Javeed Ali Shah, Jason A. Dominitz · 2021 · Clinical Infectious Diseases
  92. Combination Therapy With Tocilizumab and Dexamethasone Cost-Effectively Reduces Coronavirus Disease 2019 Mortality
    Pranay Sinha, Benjamin Paul Linas · 2021 · Clinical Infectious Diseases
  93. Cardiac Involvement in COVID-19 Patients: A Contemporary Review
    Domenico Maria Carretta, Aline Maria Silva, Donato D’Agostino, Skënder Topi, Roberto Lovero, Ioannis Alexandros Charitos, Angelika Elzbieta Wegierska, Monica Montagnani, Luigì Santacroce · 2021 · Infectious Disease Reports
  94. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19
    Simin Jamaly, Maria Tsokos, Rhea Bhargava, Olga Rachel Brook, Jonathan L. Hecht, Reza Abdi, Vaishali R. Moulton, Abhigyan Satyam, George C. Tsokos · 2021 · Clinical Immunology
  95. Electrocardiographic abnormalities in COVID-19 patients visiting the emergency department: a multicenter retrospective study
    Hugo De Carvalho, Lucas Leonard-Pons, Julien Segard, Nicolas Goffinet, François Javaudin, Arnaud Martinage, Guillaume Cattin, Severin Tiberghien, Dylan Therasse, Marc Trotignon et al. · 2021 · BMC Emergency Medicine
  96. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2
    David Alain Wohl, Amir Barzin, Sonia Napravnik, Thibaut Davy-Méndez, Jason R. Smedberg, Cecilia M. Thompson, Laura M. Ruegsegger, Matt Gilleskie, David Jay Weber, Herbert C. Whinna et al. · 2021 · PLoS ONE
  97. Differential COVID-19 Symptoms Given Pandemic Locations, Time, and Comorbidities During the Early Pandemic
    Yang Wang, Fengwei Zhang, James Brian Byrd, Hong Jie Yu, Xianwei Ye, Yongqun Oliver He · 2022 · Frontiers in Medicine
  98. Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity
    Silvio Buscemi, Davide Corleo, Cristiana Randazzo · 2021 · Advances in experimental medicine and biology
  99. SARS-CoV-2 Immunization Orchestrates the Amplification of IFNγ-Producing T Cell and NK Cell Persistence
    Lucia La Sala, Sara Gandini, Antonino Bruno, Raffaele Allevi, Matteo Gallazzi, Pamela Senesi, Maria Teresa Palano, Paola Meregalli, Ermanno Longhi, Carmen Sommese et al. · 2022 · Frontiers in Immunology
  100. The acute and chronic implications of the COVID-19 virus on the cardiovascular system in adults: A systematic review
    Ruth E. M. Ashton, B E Phillips, Mark A. Faghy · 2023 · Progress in Cardiovascular Diseases